StonvexLoading…
StonvexStonvexStonvexCore line items from QNST's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Q4 2025 2025-12-31 | Q3 2025 2025-09-30 | Q1 2025 2025-03-31 |
|---|---|---|---|---|
Revenue | $919.84M | $573.70M | $285.85M | $831.66M |
Operating Income | $16.30M | $6.04M | $4.79M | $2.32M |
Net Income | $62.12M | $54.76M | $4.54M | $1.50M |
EPS (Diluted) | $1.07 | $0.94 | $0.08 | $0.03 |
Total Assets | $704.34M | $493.03M | $442.64M | $417.24M |
Total Liabilities | $393.95M | $198.59M | $195.94M | $181.76M |
Cash & Equivalents | $102.04M | $106.96M | $101.30M | $81.81M |
Free Cash Flow OCF − CapEx | $75.56M | $39.16M | $18.43M | $53.56M |
Shares Outstanding | 57.44M | 56.99M | 57.37M | 56.94M |